Consolidated dialysis markets have coincided with both positive and negative trends in health care costs and outcomes. If the underlying mechanisms that contributed to past consolidation persist, dialysis markets may remain highly concentrated over the long term.
Maryam Saeed, Vivian Ho, Kevin EricksonJanuary 12, 2020
The authors investigate the benefits of joint investment planning for transmission lines and energy storage, finding that energy storage investments complement transmission expansion and contribute to higher social welfare values. Published by Energy Strategy Reviews: http://bit.ly/2vd2ZLA.
New research finds that health care consolidation and the integration of hospital and doctor services not only fail to improve quality but also reduce patient satisfaction.
By Philip W. Chui, Craig S. Parzynski, Joseph S. Ross, Nihar R. Desai, Hitinder S. Gurm, John A. Spertus, Arnold h. Seto, Vivian Ho and Jeptha P. Curtis
Certificate of need regulations are intended to coordinate new health care services, limit expansion of unnecessary new infrastructure and limit health care costs. This study characterizes the association between state regulations and the appropriateness and outcomes of percutaneous coronary interventions. JAHA: https://bit.ly/2QSWMNa
Federal mandates have affected nearly all areas of dialysis care delivery. Nonresident scholar Kevin F. Erickson and Wolfgang C. Winkelmayer evaluate the evidence behind two prior federal mandates to assess how the quality of evidence supporting each policy contributed to its overall success.
Kevin Erickson, Wolfgang WinkelmayerNovember 30, 2018
This paper proposes a new regulatory incentive mechanism to induce efficient investment in electricity transmission networks. Energy Economics: http://bit.ly/2PeCEpu
The author reviews some of the regulatory, financial and planning challenges for electricity transmission. Economics of Energy & Environmental Policy symposium: http://bit.ly/2KMRUvf.
A growing number of stem cell clinics treat a variety of illnesses and injuries, yet few have conducted the necessary clinical research to ensure safety and efficacy.
The authors highlight the importance of collaboration between scientists, regulators, patients and patient advocates in developing effective policies and practices for unproven stem cell-based intervention clinics.
Krane finds that the coal industry is at greater risk of being targeted by climate-related regulation amid decreasing social acceptance of its use, while the oil industry faces reduced risks due to its lack of substitutes.
This journal article examines the risks patients face in seeking experimental stem cell-based interventions from clinics outside the United States. The authors advocate for new public policies that encourage patients to remain in clinical trials in the U.S.
Kirstin R.W. Matthews, Ana S. IltisNovember 4, 2015